Advertisement
Screener

Personalis, Inc. (PSNL) Graph

PSNL Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $22.36M; Cost of revenue $17.61M; Research and development $16.34M; Selling, general and administrative $22.00M.
  • 2026-03-31: Revenue $15.47M; Cost of revenue $15.19M; Research and development $14.54M; Selling, general and administrative $17.90M.
  • 2025-12-31: Revenue $17.34M*; Cost of revenue $15.45M*; Research and development $13.07M*; Selling, general and administrative $14.09M*.
  • 2025-09-30: Revenue $14.49M; Cost of revenue $12.58M; Research and development $12.17M; Selling, general and administrative $13.03M.

Major Customers

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PSNL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Clinical Diagnostic$2.54MEnterprise Sales$0.00Other$27.00KPharma TestingServices$16.79MPopulation Sequencing$3.00MRevenue$22.36MCost of revenue$17.61MOperating income-$33.59MOther income, net-$16.00KResearch & development$16.34MSelling, general& administrative$22.00MPre-tax income-$31.68MIncome tax$5.00KNet income-$31.68M

Related Party Transactions By Related Party

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PSNL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Related Party$8.40MRevenue$22.36MCost of revenue$17.61MOperating income-$33.59MOther income, net-$16.00KResearch & development$16.34MSelling, general& administrative$22.00MPre-tax income-$31.68MIncome tax$5.00KNet income-$31.68M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$22.36M$17.61M$16.34M$22.00M$5.00K-$31.68M
2026-03-31$15.47M$15.19M$14.54M$17.90M$16.00K-$30.03M
2025-12-31$17.34M*$15.45M*$13.07M*$14.09M*$9.00K*-$23.81M*
2025-09-30$14.49M$12.58M$12.17M$13.03M$3.00K-$21.65M
2025-06-30$17.20M$12.45M$12.38M$14.18M$2.00K-$20.06M
2025-03-31$20.61M$13.40M$12.64M$12.26M$7.00K-$15.75M
2024-09-30$25.71M$16.96M$11.68M$11.44M$3.00K-$39.09M
2024-06-30$22.58M$14.54M$12.96M$11.97M$4.00K-$12.80M
2024-03-31$19.52M$14.03M$12.77M$11.60M$7.00K-$12.97M
2023-09-30$18.25M$14.77M$16.74M$11.97M$28.00K-$29.10M
2023-06-30$16.70M$11.91M$17.85M$12.13M$36.00K-$23.95M
2023-03-31$18.86M$14.13M$16.57M$14.10M$14.00K-$28.66M
2022-09-30$14.86M$12.38M$14.96M$14.78M$11.00K-$26.49M
2022-06-30$18.24M$13.96M$16.29M$15.87M$14.00K-$27.55M
2022-03-31$15.23M$10.95M$17.10M$15.49M$7.00K-$28.21M
2021-09-30$22.26M$14.20M$13.62M$12.14M$12.00K-$17.67M
2021-06-30$21.67M$13.50M$11.69M$11.43M$8.00K-$14.95M
2021-03-31$20.88M$13.45M$9.50M$10.42M-$3.00K-$12.40M
2020-09-30$19.82M$14.48M$7.19M$7.79M$5.00K-$9.54M
2020-06-30$19.50M$14.82M$6.46M$7.71M$4.00K-$9.26M
2020-03-31$19.16M$15.12M$6.39M$7.27M$30.00K-$9.14M
2019-12-31$18.15M(m)(m)(m)(m)-$6.64M
2019-09-30$17.15M$11.52M$5.30M$6.06M$1.00K-$6.88M
2019-06-30$15.82M$9.92M$4.50M$5.47M$2.00K-$5.87M
2019-03-31$14.07M$10.09M$5.25M$4.17M$2.00K-$5.68M
2018-12-31$13.16M(m)(m)(m)(m)-$3.56M
2018-09-30$11.65M$7.17M$3.57M$2.66M$2.00K-$3.64M
2018-06-30$8.80M$6.40M$3.50M$2.60M$1.00K-$7.32M
2018-03-31$4.16M(m)(m)(m)(m)-$5.38M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$37.83M$32.80M$30.88M$39.90M$21.00K-$61.72M
2025-06-30$37.81M$25.84M$25.02M$26.44M$9.00K-$35.81M
2024-06-30$42.10M$28.57M$25.73M$23.57M$11.00K-$25.77M
2023-06-30$35.56M$26.04M$34.42M$26.23M$50.00K-$52.61M
2022-06-30$33.47M$24.91M$33.39M$31.36M$21.00K-$55.76M
2021-06-30$42.55M$26.96M$21.18M$21.85M$5.00K-$27.36M
2020-06-30$38.66M$29.95M$12.86M$14.98M$34.00K-$18.39M
2019-06-30$29.90M$20.01M$9.74M$9.64M$4.00K-$11.55M
2018-06-30$12.96M$10.47M$6.45M$4.92M$3.00K-$12.69M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$52.30M$38.43M$37.19M$39.48M$12.00K-$57.46M
2024-09-30$67.81M$45.54M$37.41M$35.02M$14.00K-$64.86M
2023-09-30$53.81M$40.80M$51.16M$38.20M$78.00K-$81.71M
2022-09-30$48.33M$37.29M$48.34M$46.14M$32.00K-$82.25M
2021-09-30$64.81M$41.15M$34.80M$33.99M$17.00K-$45.03M
2020-09-30$58.47M$44.43M$20.05M$22.77M$39.00K-$27.94M
2019-09-30$47.05M$31.54M$15.04M$15.69M$5.00K-$18.44M
2018-09-30$24.62M$17.64M$10.02M$7.58M$5.00K-$16.33M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$69.65M$53.87M$50.26M$53.57M$21.00K-$81.27M
2024-12-31$84.61M$57.79M$48.91M$46.19M$18.00K-$81.28M
2023-12-31$73.48M$55.27M$64.78M$49.73M$83.00K-$108.30M
2022-12-31$65.05M$51.70M$64.91M$63.97M$40.00K-$113.31M
2021-12-31$85.49M$53.84M$49.31M$47.70M$14.00K-$65.23M
2020-12-31$78.65M$58.53M$28.57M$33.69M$57.00K-$41.28M
2019-12-31$65.21M$43.13M$22.42M$22.08M$9.00K-$25.08M
2018-12-31$37.77M$25.97M$14.30M$11.27M$7.00K-$19.89M
2017-12-31$9.39M$11.74M$9.92M$9.90M$5.00K-$23.60M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
CareDx, Inc. (CDNA)United States$3.174B13.21
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64